 | • レポートコード：MRC2-11QY07179 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は酢酸ロイプロリドのグローバル市場について調査・分析したレポートです。種類別（筋肉内、皮下）市場規模、用途別（前立腺がん、早熟、子宮筋腫、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別酢酸ロイプロリドの競争状況、市場シェア ・世界の酢酸ロイプロリド市場：種類別市場規模 2015年-2020年（筋肉内、皮下） ・世界の酢酸ロイプロリド市場：種類別市場規模予測 2021年-2026年（筋肉内、皮下） ・世界の酢酸ロイプロリド市場：用途別市場規模 2015年-2020年（前立腺がん、早熟、子宮筋腫、その他） ・世界の酢酸ロイプロリド市場：用途別市場規模予測 2021年-2026年（前立腺がん、早熟、子宮筋腫、その他） ・北米の酢酸ロイプロリド市場分析：米国、カナダ ・ヨーロッパの酢酸ロイプロリド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの酢酸ロイプロリド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の酢酸ロイプロリド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの酢酸ロイプロリド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Tolmar Pharmaceuticals、Varian Pharmed、Avenit、Takeda Pharmaceutical、Sun Pharmaceutical Industries、Livzon Pharmaceutical、Beijing Biote Pharmaceutical、Soho-YImIng、AbbVie、Sanofi、Astellas Pharma、Abbott、Merck、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.
Market Analysis and Insights: Global Leuprolide Acetate Market
The global Leuprolide Acetate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Leuprolide Acetate Scope and Market Size
Leuprolide Acetate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leuprolide Acetate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Leuprolide Acetate market is segmented into
Intramuscular
Subcutaneous
Segment by Application, the Leuprolide Acetate market is segmented into
Prostate Cancer
Precocious
Uterine Fibroid
Others
Regional and Country-level Analysis
The Leuprolide Acetate market is analysed and market size information is provided by regions (countries).
The key regions covered in the Leuprolide Acetate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Leuprolide Acetate Market Share Analysis
Leuprolide Acetate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Leuprolide Acetate business, the date to enter into the Leuprolide Acetate market, Leuprolide Acetate product introduction, recent developments, etc.
The major vendors covered:
Tolmar Pharmaceuticals
Varian Pharmed
Avenit
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Livzon Pharmaceutical
Beijing Biote Pharmaceutical
Soho-YImIng
AbbVie
Sanofi
Astellas Pharma
Abbott
Merck
Pfizer
1 Study Coverage
1.1 Leuprolide Acetate Product Introduction
1.2 Market Segments
1.3 Key Leuprolide Acetate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Leuprolide Acetate Market Size Growth Rate by Type
1.4.2 Intramuscular
1.4.3 Subcutaneous
1.5 Market by Application
1.5.1 Global Leuprolide Acetate Market Size Growth Rate by Application
1.5.2 Prostate Cancer
1.5.3 Precocious
1.5.4 Uterine Fibroid
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Leuprolide Acetate Market Size, Estimates and Forecasts
2.1.1 Global Leuprolide Acetate Revenue 2015-2026
2.1.2 Global Leuprolide Acetate Sales 2015-2026
2.2 Global Leuprolide Acetate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Leuprolide Acetate Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Leuprolide Acetate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Leuprolide Acetate Competitor Landscape by Players
3.1 Leuprolide Acetate Sales by Manufacturers
3.1.1 Leuprolide Acetate Sales by Manufacturers (2015-2020)
3.1.2 Leuprolide Acetate Sales Market Share by Manufacturers (2015-2020)
3.2 Leuprolide Acetate Revenue by Manufacturers
3.2.1 Leuprolide Acetate Revenue by Manufacturers (2015-2020)
3.2.2 Leuprolide Acetate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Leuprolide Acetate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Leuprolide Acetate Revenue in 2019
3.2.5 Global Leuprolide Acetate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Leuprolide Acetate Price by Manufacturers
3.4 Leuprolide Acetate Manufacturing Base Distribution, Product Types
3.4.1 Leuprolide Acetate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Leuprolide Acetate Product Type
3.4.3 Date of International Manufacturers Enter into Leuprolide Acetate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Leuprolide Acetate Market Size by Type (2015-2020)
4.1.1 Global Leuprolide Acetate Sales by Type (2015-2020)
4.1.2 Global Leuprolide Acetate Revenue by Type (2015-2020)
4.1.3 Leuprolide Acetate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Leuprolide Acetate Market Size Forecast by Type (2021-2026)
4.2.1 Global Leuprolide Acetate Sales Forecast by Type (2021-2026)
4.2.2 Global Leuprolide Acetate Revenue Forecast by Type (2021-2026)
4.2.3 Leuprolide Acetate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Leuprolide Acetate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Leuprolide Acetate Market Size by Application (2015-2020)
5.1.1 Global Leuprolide Acetate Sales by Application (2015-2020)
5.1.2 Global Leuprolide Acetate Revenue by Application (2015-2020)
5.1.3 Leuprolide Acetate Price by Application (2015-2020)
5.2 Leuprolide Acetate Market Size Forecast by Application (2021-2026)
5.2.1 Global Leuprolide Acetate Sales Forecast by Application (2021-2026)
5.2.2 Global Leuprolide Acetate Revenue Forecast by Application (2021-2026)
5.2.3 Global Leuprolide Acetate Price Forecast by Application (2021-2026)
6 North America
6.1 North America Leuprolide Acetate by Country
6.1.1 North America Leuprolide Acetate Sales by Country
6.1.2 North America Leuprolide Acetate Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Leuprolide Acetate Market Facts & Figures by Type
6.3 North America Leuprolide Acetate Market Facts & Figures by Application
7 Europe
7.1 Europe Leuprolide Acetate by Country
7.1.1 Europe Leuprolide Acetate Sales by Country
7.1.2 Europe Leuprolide Acetate Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Leuprolide Acetate Market Facts & Figures by Type
7.3 Europe Leuprolide Acetate Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Leuprolide Acetate by Region
8.1.1 Asia Pacific Leuprolide Acetate Sales by Region
8.1.2 Asia Pacific Leuprolide Acetate Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Leuprolide Acetate Market Facts & Figures by Type
8.3 Asia Pacific Leuprolide Acetate Market Facts & Figures by Application
9 Latin America
9.1 Latin America Leuprolide Acetate by Country
9.1.1 Latin America Leuprolide Acetate Sales by Country
9.1.2 Latin America Leuprolide Acetate Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Leuprolide Acetate Market Facts & Figures by Type
9.3 Central & South America Leuprolide Acetate Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Leuprolide Acetate by Country
10.1.1 Middle East and Africa Leuprolide Acetate Sales by Country
10.1.2 Middle East and Africa Leuprolide Acetate Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Leuprolide Acetate Market Facts & Figures by Type
10.3 Middle East and Africa Leuprolide Acetate Market Facts & Figures by Application
11 Company Profiles
11.1 Tolmar Pharmaceuticals
11.1.1 Tolmar Pharmaceuticals Corporation Information
11.1.2 Tolmar Pharmaceuticals Description and Business Overview
11.1.3 Tolmar Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Tolmar Pharmaceuticals Leuprolide Acetate Products Offered
11.1.5 Tolmar Pharmaceuticals Related Developments
11.2 Varian Pharmed
11.2.1 Varian Pharmed Corporation Information
11.2.2 Varian Pharmed Description and Business Overview
11.2.3 Varian Pharmed Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Varian Pharmed Leuprolide Acetate Products Offered
11.2.5 Varian Pharmed Related Developments
11.3 Avenit
11.3.1 Avenit Corporation Information
11.3.2 Avenit Description and Business Overview
11.3.3 Avenit Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Avenit Leuprolide Acetate Products Offered
11.3.5 Avenit Related Developments
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Corporation Information
11.4.2 Takeda Pharmaceutical Description and Business Overview
11.4.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Pharmaceutical Leuprolide Acetate Products Offered
11.4.5 Takeda Pharmaceutical Related Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Corporation Information
11.5.2 Sun Pharmaceutical Industries Description and Business Overview
11.5.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sun Pharmaceutical Industries Leuprolide Acetate Products Offered
11.5.5 Sun Pharmaceutical Industries Related Developments
11.6 Livzon Pharmaceutical
11.6.1 Livzon Pharmaceutical Corporation Information
11.6.2 Livzon Pharmaceutical Description and Business Overview
11.6.3 Livzon Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Livzon Pharmaceutical Leuprolide Acetate Products Offered
11.6.5 Livzon Pharmaceutical Related Developments
11.7 Beijing Biote Pharmaceutical
11.7.1 Beijing Biote Pharmaceutical Corporation Information
11.7.2 Beijing Biote Pharmaceutical Description and Business Overview
11.7.3 Beijing Biote Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Beijing Biote Pharmaceutical Leuprolide Acetate Products Offered
11.7.5 Beijing Biote Pharmaceutical Related Developments
11.8 Soho-YImIng
11.8.1 Soho-YImIng Corporation Information
11.8.2 Soho-YImIng Description and Business Overview
11.8.3 Soho-YImIng Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Soho-YImIng Leuprolide Acetate Products Offered
11.8.5 Soho-YImIng Related Developments
11.9 AbbVie
11.9.1 AbbVie Corporation Information
11.9.2 AbbVie Description and Business Overview
11.9.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AbbVie Leuprolide Acetate Products Offered
11.9.5 AbbVie Related Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Description and Business Overview
11.10.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sanofi Leuprolide Acetate Products Offered
11.10.5 Sanofi Related Developments
11.1 Tolmar Pharmaceuticals
11.1.1 Tolmar Pharmaceuticals Corporation Information
11.1.2 Tolmar Pharmaceuticals Description and Business Overview
11.1.3 Tolmar Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Tolmar Pharmaceuticals Leuprolide Acetate Products Offered
11.1.5 Tolmar Pharmaceuticals Related Developments
11.12 Abbott
11.12.1 Abbott Corporation Information
11.12.2 Abbott Description and Business Overview
11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Abbott Products Offered
11.12.5 Abbott Related Developments
11.13 Merck
11.13.1 Merck Corporation Information
11.13.2 Merck Description and Business Overview
11.13.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Merck Products Offered
11.13.5 Merck Related Developments
11.14 Pfizer
11.14.1 Pfizer Corporation Information
11.14.2 Pfizer Description and Business Overview
11.14.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Pfizer Products Offered
11.14.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Leuprolide Acetate Market Estimates and Projections by Region
12.1.1 Global Leuprolide Acetate Sales Forecast by Regions 2021-2026
12.1.2 Global Leuprolide Acetate Revenue Forecast by Regions 2021-2026
12.2 North America Leuprolide Acetate Market Size Forecast (2021-2026)
12.2.1 North America: Leuprolide Acetate Sales Forecast (2021-2026)
12.2.2 North America: Leuprolide Acetate Revenue Forecast (2021-2026)
12.2.3 North America: Leuprolide Acetate Market Size Forecast by Country (2021-2026)
12.3 Europe Leuprolide Acetate Market Size Forecast (2021-2026)
12.3.1 Europe: Leuprolide Acetate Sales Forecast (2021-2026)
12.3.2 Europe: Leuprolide Acetate Revenue Forecast (2021-2026)
12.3.3 Europe: Leuprolide Acetate Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Leuprolide Acetate Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Leuprolide Acetate Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Leuprolide Acetate Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Leuprolide Acetate Market Size Forecast by Region (2021-2026)
12.5 Latin America Leuprolide Acetate Market Size Forecast (2021-2026)
12.5.1 Latin America: Leuprolide Acetate Sales Forecast (2021-2026)
12.5.2 Latin America: Leuprolide Acetate Revenue Forecast (2021-2026)
12.5.3 Latin America: Leuprolide Acetate Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Leuprolide Acetate Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Leuprolide Acetate Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Leuprolide Acetate Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Leuprolide Acetate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Leuprolide Acetate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Leuprolide Acetate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Leuprolide Acetate Market Segments
Table 2. Ranking of Global Top Leuprolide Acetate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Leuprolide Acetate Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular
Table 5. Major Manufacturers of Subcutaneous
Table 6. Global Leuprolide Acetate Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Leuprolide Acetate Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Leuprolide Acetate Sales by Regions 2015-2020 (K Units)
Table 9. Global Leuprolide Acetate Sales Market Share by Regions (2015-2020)
Table 10. Global Leuprolide Acetate Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Leuprolide Acetate Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Leuprolide Acetate Sales Share by Manufacturers (2015-2020)
Table 13. Global Leuprolide Acetate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Leuprolide Acetate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leuprolide Acetate as of 2019)
Table 15. Leuprolide Acetate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Leuprolide Acetate Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Leuprolide Acetate Price (2015-2020) (USD/Unit)
Table 18. Leuprolide Acetate Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Leuprolide Acetate Product Type
Table 20. Date of International Manufacturers Enter into Leuprolide Acetate Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 23. Global Leuprolide Acetate Sales Share by Type (2015-2020)
Table 24. Global Leuprolide Acetate Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Leuprolide Acetate Revenue Share by Type (2015-2020)
Table 26. Leuprolide Acetate Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 28. Global Leuprolide Acetate Sales Share by Application (2015-2020)
Table 29. North America Leuprolide Acetate Sales by Country (2015-2020) (K Units)
Table 30. North America Leuprolide Acetate Sales Market Share by Country (2015-2020)
Table 31. North America Leuprolide Acetate Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Leuprolide Acetate Revenue Market Share by Country (2015-2020)
Table 33. North America Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 34. North America Leuprolide Acetate Sales Market Share by Type (2015-2020)
Table 35. North America Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 36. North America Leuprolide Acetate Sales Market Share by Application (2015-2020)
Table 37. Europe Leuprolide Acetate Sales by Country (2015-2020) (K Units)
Table 38. Europe Leuprolide Acetate Sales Market Share by Country (2015-2020)
Table 39. Europe Leuprolide Acetate Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Leuprolide Acetate Revenue Market Share by Country (2015-2020)
Table 41. Europe Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 42. Europe Leuprolide Acetate Sales Market Share by Type (2015-2020)
Table 43. Europe Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 44. Europe Leuprolide Acetate Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Leuprolide Acetate Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Leuprolide Acetate Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Leuprolide Acetate Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Leuprolide Acetate Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Leuprolide Acetate Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Leuprolide Acetate Sales Market Share by Application (2015-2020)
Table 53. Latin America Leuprolide Acetate Sales by Country (2015-2020) (K Units)
Table 54. Latin America Leuprolide Acetate Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Leuprolide Acetate Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Leuprolide Acetate Revenue Market Share by Country (2015-2020)
Table 57. Latin America Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 58. Latin America Leuprolide Acetate Sales Market Share by Type (2015-2020)
Table 59. Latin America Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 60. Latin America Leuprolide Acetate Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Leuprolide Acetate Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Leuprolide Acetate Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Leuprolide Acetate Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Leuprolide Acetate Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Leuprolide Acetate Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Leuprolide Acetate Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Leuprolide Acetate Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Leuprolide Acetate Sales Market Share by Application (2015-2020)
Table 69. Tolmar Pharmaceuticals Corporation Information
Table 70. Tolmar Pharmaceuticals Description and Major Businesses
Table 71. Tolmar Pharmaceuticals Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Tolmar Pharmaceuticals Product
Table 73. Tolmar Pharmaceuticals Recent Development
Table 74. Varian Pharmed Corporation Information
Table 75. Varian Pharmed Description and Major Businesses
Table 76. Varian Pharmed Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Varian Pharmed Product
Table 78. Varian Pharmed Recent Development
Table 79. Avenit Corporation Information
Table 80. Avenit Description and Major Businesses
Table 81. Avenit Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Avenit Product
Table 83. Avenit Recent Development
Table 84. Takeda Pharmaceutical Corporation Information
Table 85. Takeda Pharmaceutical Description and Major Businesses
Table 86. Takeda Pharmaceutical Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Takeda Pharmaceutical Product
Table 88. Takeda Pharmaceutical Recent Development
Table 89. Sun Pharmaceutical Industries Corporation Information
Table 90. Sun Pharmaceutical Industries Description and Major Businesses
Table 91. Sun Pharmaceutical Industries Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Sun Pharmaceutical Industries Product
Table 93. Sun Pharmaceutical Industries Recent Development
Table 94. Livzon Pharmaceutical Corporation Information
Table 95. Livzon Pharmaceutical Description and Major Businesses
Table 96. Livzon Pharmaceutical Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Livzon Pharmaceutical Product
Table 98. Livzon Pharmaceutical Recent Development
Table 99. Beijing Biote Pharmaceutical Corporation Information
Table 100. Beijing Biote Pharmaceutical Description and Major Businesses
Table 101. Beijing Biote Pharmaceutical Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Beijing Biote Pharmaceutical Product
Table 103. Beijing Biote Pharmaceutical Recent Development
Table 104. Soho-YImIng Corporation Information
Table 105. Soho-YImIng Description and Major Businesses
Table 106. Soho-YImIng Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Soho-YImIng Product
Table 108. Soho-YImIng Recent Development
Table 109. AbbVie Corporation Information
Table 110. AbbVie Description and Major Businesses
Table 111. AbbVie Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. AbbVie Product
Table 113. AbbVie Recent Development
Table 114. Sanofi Corporation Information
Table 115. Sanofi Description and Major Businesses
Table 116. Sanofi Leuprolide Acetate Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Sanofi Product
Table 118. Sanofi Recent Development
Table 119. Astellas Pharma Corporation Information
Table 120. Astellas Pharma Description and Major Businesses
Table 121. Astellas Pharma Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Astellas Pharma Product
Table 123. Astellas Pharma Recent Development
Table 124. Abbott Corporation Information
Table 125. Abbott Description and Major Businesses
Table 126. Abbott Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Abbott Product
Table 128. Abbott Recent Development
Table 129. Merck Corporation Information
Table 130. Merck Description and Major Businesses
Table 131. Merck Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Merck Product
Table 133. Merck Recent Development
Table 134. Pfizer Corporation Information
Table 135. Pfizer Description and Major Businesses
Table 136. Pfizer Leuprolide Acetate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Pfizer Product
Table 138. Pfizer Recent Development
Table 139. Global Leuprolide Acetate Sales Forecast by Regions (2021-2026) (K Units)
Table 140. Global Leuprolide Acetate Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Leuprolide Acetate Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Leuprolide Acetate Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Leuprolide Acetate Sales Forecast by Country (2021-2026) (K Units)
Table 144. North America: Leuprolide Acetate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Leuprolide Acetate Sales Forecast by Country (2021-2026) (K Units)
Table 146. Europe: Leuprolide Acetate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Leuprolide Acetate Sales Forecast by Region (2021-2026) (K Units)
Table 148. Asia Pacific: Leuprolide Acetate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Leuprolide Acetate Sales Forecast by Country (2021-2026) (K Units)
Table 150. Latin America: Leuprolide Acetate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Leuprolide Acetate Sales Forecast by Country (2021-2026) (K Units)
Table 152. Middle East and Africa: Leuprolide Acetate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Leuprolide Acetate Players
Table 157. Leuprolide Acetate Customers List
Table 158. Leuprolide Acetate Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Leuprolide Acetate Product Picture
Figure 2. Global Leuprolide Acetate Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Product Picture
Figure 4. Subcutaneous Product Picture
Figure 5. Global Leuprolide Acetate Sales Market Share by Application in 2020 & 2026
Figure 6. Prostate Cancer
Figure 7. Precocious
Figure 8. Uterine Fibroid
Figure 9. Others
Figure 10. Leuprolide Acetate Report Years Considered
Figure 11. Global Leuprolide Acetate Market Size 2015-2026 (US$ Million)
Figure 12. Global Leuprolide Acetate Sales 2015-2026 (K Units)
Figure 13. Global Leuprolide Acetate Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Leuprolide Acetate Sales Market Share by Region (2015-2020)
Figure 15. Global Leuprolide Acetate Sales Market Share by Region in 2019
Figure 16. Global Leuprolide Acetate Revenue Market Share by Region (2015-2020)
Figure 17. Global Leuprolide Acetate Revenue Market Share by Region in 2019
Figure 18. Global Leuprolide Acetate Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Leuprolide Acetate Revenue in 2019
Figure 20. Leuprolide Acetate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Leuprolide Acetate Sales Market Share by Type (2015-2020)
Figure 22. Global Leuprolide Acetate Sales Market Share by Type in 2019
Figure 23. Global Leuprolide Acetate Revenue Market Share by Type (2015-2020)
Figure 24. Global Leuprolide Acetate Revenue Market Share by Type in 2019
Figure 25. Global Leuprolide Acetate Market Share by Price Range (2015-2020)
Figure 26. Global Leuprolide Acetate Sales Market Share by Application (2015-2020)
Figure 27. Global Leuprolide Acetate Sales Market Share by Application in 2019
Figure 28. Global Leuprolide Acetate Revenue Market Share by Application (2015-2020)
Figure 29. Global Leuprolide Acetate Revenue Market Share by Application in 2019
Figure 30. North America Leuprolide Acetate Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Leuprolide Acetate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Leuprolide Acetate Sales Market Share by Country in 2019
Figure 33. North America Leuprolide Acetate Revenue Market Share by Country in 2019
Figure 34. U.S. Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Leuprolide Acetate Market Share by Type in 2019
Figure 39. North America Leuprolide Acetate Market Share by Application in 2019
Figure 40. Europe Leuprolide Acetate Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Leuprolide Acetate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Leuprolide Acetate Sales Market Share by Country in 2019
Figure 43. Europe Leuprolide Acetate Revenue Market Share by Country in 2019
Figure 44. Germany Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Leuprolide Acetate Market Share by Type in 2019
Figure 55. Europe Leuprolide Acetate Market Share by Application in 2019
Figure 56. Asia Pacific Leuprolide Acetate Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Leuprolide Acetate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Leuprolide Acetate Sales Market Share by Region in 2019
Figure 59. Asia Pacific Leuprolide Acetate Revenue Market Share by Region in 2019
Figure 60. China Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Leuprolide Acetate Market Share by Type in 2019
Figure 83. Asia Pacific Leuprolide Acetate Market Share by Application in 2019
Figure 84. Latin America Leuprolide Acetate Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Leuprolide Acetate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Leuprolide Acetate Sales Market Share by Country in 2019
Figure 87. Latin America Leuprolide Acetate Revenue Market Share by Country in 2019
Figure 88. Mexico Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Leuprolide Acetate Market Share by Type in 2019
Figure 95. Latin America Leuprolide Acetate Market Share by Application in 2019
Figure 96. Middle East and Africa Leuprolide Acetate Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Leuprolide Acetate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Leuprolide Acetate Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Leuprolide Acetate Revenue Market Share by Country in 2019
Figure 100. Turkey Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Leuprolide Acetate Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Leuprolide Acetate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Leuprolide Acetate Market Share by Type in 2019
Figure 107. Middle East and Africa Leuprolide Acetate Market Share by Application in 2019
Figure 108. North America Leuprolide Acetate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Leuprolide Acetate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Leuprolide Acetate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Leuprolide Acetate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Leuprolide Acetate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Leuprolide Acetate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Leuprolide Acetate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Leuprolide Acetate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Leuprolide Acetate Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Leuprolide Acetate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
酢酸ナトリウム三水和物および酢酸ナトリウム無水物の世界市場（～2026年） Sodium acetate, also known as sodium ethanoate, can be synthesized by reacting acetic acid with sodium carbonate or sodium hydroxide. Sodium acetate trihydrate is a granular, crystalline powder with acetic odor, while sodium acetate anhydrous is a granular, hygroscopic powder. Sodium acetate trihydr…- ビタミンEアセテートの世界市場（～2026年） Market Analysis and Insights: Global Vitamin E Acetate Market The global Vitamin E Acetate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vitamin E Acetate Scope and Market Size Vitamin E Acetate market is segmented b…
- 酢酸セルロースの世界市場（～2026年） Cellulose acetate is the acetate ester of cellulose. It was first prepared in 1865. Cellulose acetate is used as a film base in photography, as a component in some coatings, and as a frame material for eyeglasses;it is also used as a synthetic fiberin the manufacture of cigarette filters and playing…
- 酢酸セルロース繊維の世界市場（～2026年） Market Analysis and Insights: Global Cellulose Acetate Fiber Market The global Cellulose Acetate Fiber market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cellulose Acetate Fiber Scope and Market Size Cellulose Acetate Fib…
- 酢酸ブチル（BAC）の世界市場（～2026年） BAC is a volatile, colorless solvent with a characteristic ester odor. It is also an excellent solvent for cellulose nitrate, polymers, resins, and oils. BAC can be formulated using both bio-based and synthetic methods. Rising demand from Asia-Pacific region a major driver for the growth of the Buty…